Search results
Magic Mushrooms Get Canadian Export License in Psychedelic Race
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Canada has licensed a startup to export psychedelics to Australia for patient use,...
Dosing Continues in Lexaria’s Second GLP-1 Human Pilot Study
Digital Journal· 3 days agoSecond study arm dosing is now complete. KELOWNA, BC / ACCESSWIRE / June 5, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoRNAi Therapeutics and Technology Market Worth USD 5.36 Billion by 2031 at 16.6% CAGR- Exclusive Report by InsightAce Analytic Pvt. Ltd. PR Newswire JERSEY CITY, N.J., June 4, 2024 JERSEY CITY, N.J., June 4, 2024 /PRNewswire/ -- InsightAce Analytic
NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders
Digital Journal· 4 days agoNurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoNEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company< ...
Male birth control gel shows promise in early-stage clinical trials
The Day· 2 days agoIn the realm of reproductive health, male birth control has loomed as a long-standing quest. Recently, a combination hormonal topical gel has shown promise by suppressing sperm production in ...
The Dividend Dominators: 3 Stocks That Will Make Your Portfolio Reign Supreme
InvestorPlace· 4 days agoThe timing is perfect for loading up on dividend stocks as market experts expect the S&P 500 to...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoPharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) ...